Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Filings indexed 553 across all filing types
Latest filing 2025-04-03 M&A Activity
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
증권신고서(합병)
M&A Activity Classification · 1% confidence The document is a '증권신고서(합병)' (Securities Registration Statement for Merger) filed with the Financial Services Commission (FSC) in South Korea. It details the merger between HLB Co., Ltd. and HLB Life Science Co., Ltd., including business risks, financial information, and investment considerations. This is a formal regulatory filing required for corporate mergers and acquisitions under Korean capital market laws.
2025-04-03 Korean
주주명부폐쇄기간또는기준일설정
Capital/Financing Update Classification · 1% confidence The document is a short regulatory notice regarding the setting of a record date for shareholder list closure, specifically for the purpose of identifying shareholders with dissent rights in a small-scale merger. It is a standard corporate disclosure filed with the exchange (KRX) and does not constitute the merger agreement or the full financial report itself. Given its nature as a specific regulatory disclosure regarding corporate actions, it fits best under the RNS (Regulatory Filings) category.
2025-04-01 Korean
[첨부추가]주요사항보고서(회사합병결정)
M&A Activity Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding a corporate merger (회사합병 결정) between HLB Co., Ltd. and HLB Life Science Co., Ltd. This type of regulatory filing, which details the terms, purpose, and impact of a merger, falls under the category of M&A activity announcements.
2025-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results from a company's Annual General Meeting (AGM), specifically detailing the approval of financial statements, election of directors, and voting outcomes on various agenda items. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2025-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of a new outside director (Yang Chung-mo) for HLB Co., Ltd. This falls under the category of board management and changes, which is classified as MANG.
2025-03-31 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location, purpose, and target audience for the meeting. Since this is an announcement of an event rather than the presentation materials themselves, and it is a short regulatory notice, it falls under the category of a Report Publication Announcement or general regulatory filing. Given the specific nature of announcing an IR event, it is best classified as a Report Publication Announcement (RPA).
2025-03-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.